What are the recommended doses of montelukast and levocetirizine for an adult with chronic kidney disease?

Montelukast and Levocetirizine Dosing in CKD

For montelukast, no dose adjustment is required in chronic kidney disease as it is eliminated via bile, not urine; for levocetirizine, reduce the dose by 50% in moderate renal impairment (CrCl 10-80 mL/min) and avoid completely in severe renal impairment (CrCl <10 mL/min). 1, 2

Montelukast Dosing in CKD

• Standard adult dose: 10 mg once daily in the evening - no adjustment needed regardless of renal function 1
• Montelukast and its metabolites are excreted almost exclusively via bile (86% fecal, <0.2% urine) 1
• The FDA drug label explicitly states: "Since montelukast and its metabolites are not excreted in the urine, the pharmacokinetics of montelukast were not evaluated in patients with renal insufficiency. No dosage adjustment is recommended in these patients" 1

This is straightforward - renal elimination is negligible, so kidney function doesn't affect drug clearance.

Levocetirizine Dosing in CKD

The dosing requires careful adjustment based on creatinine clearance:

Moderate Renal Impairment (CrCl 10-80 mL/min)

• Reduce dose by 50%: Give 2.5 mg once daily instead of the standard 5 mg 2
• British guidelines specifically state "the dose of cetirizine, levocetirizine and hydroxyzine should be halved" in moderate renal impairment 2

Severe Renal Impairment (CrCl <10 mL/min)

• Avoid levocetirizine completely 2
• The guideline explicitly states to avoid cetirizine and levocetirizine in severe renal impairment 2
• The FDA OTC label also states "consumers with kidney disease do not use" 3

Clinical Pitfalls to Avoid

• Don't assume both drugs need adjustment - only levocetirizine requires dose modification in CKD
• Calculate actual creatinine clearance - don't rely on serum creatinine alone, as this can lead to overdosing in elderly or low-muscle-mass patients
• Monitor for sedation - even at reduced doses, levocetirizine can accumulate in renal impairment and cause increased drowsiness
• Avoid acrivastine entirely if CrCl 10-20 mL/min (moderate impairment) - this is a different antihistamine that should be completely avoided, not just dose-reduced 2

Algorithm for Prescribing

1. Calculate creatinine clearance using Cockcroft-Gault equation
2. For montelukast: Prescribe 10 mg daily regardless of CrCl
3. For levocetirizine:
   • CrCl >80 mL/min → 5 mg daily
   • CrCl 10-80 mL/min → 2.5 mg daily
   • CrCl <10 mL/min → Do not prescribe; choose alternative antihistamine

The evidence is clear and consistent between the FDA labeling 1 and British guidelines 2, making this a straightforward dosing decision based on elimination pathways.